+ All Categories

Home > Documents > p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action:...

p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action:...

Date post:	25-Oct-2020
Category:	Documents
Upload:	others
View:	2 times
Download:	0 times

Download Report this document

Share this document with a friend

Embed Size (px):

8

Transcript

Page 1: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Page 2: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Page 3: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Page 4: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Page 5: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Page 6: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Page 7: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Page 8: p.mercycare.orgp.mercycare.org/app/files/public/115/pdf-060812-Signed-Minutes_v2.… · Action: CALGB 80101 Annual Review was discussed and approved for continuation with 8 votes

Recommended

060812 EEOC Response (ROMANIAN)

News & Politics

Eastern cooperative oncology group E1496: ECOG and CALGB Cyclophosphamide/Fludarabine (CF) with or without Maintenance Rituximab (MR) in Advanced Indolent.

060812 EEOC Response (BENGALI)

News & Politics

060812 EEOC Response (HINDI)

News & Politics

060812 EEOC Response (ALBANIAN)

News & Politics

E1496: ECOG and CALGB

060812 EEOC Response (PERSIAN)

News & Politics

Bayesian Machine Learning on CALGB/SWOG 80405 (Alliance ...€¦ · Basic Colon Cancer Poster presented at:!"#$%&'($) *$&+!,) ¥ 2110 patients from CALGB/SWOG 80405 and 228 patients

CALGB 90401: A randomized double-blind placebo controlled phase III trial comparing docetaxel, prednisone…

060812 EEOC Response (WELSH)

News & Politics

060812 EEOC Response (BULGARIAN)

News & Politics

060812 EEOC Response (SPANISH)

News & Politics

060812 EEOC Response (TURKISH)

News & Politics

French Apartments Brochure, Call 80101-37838

New Developments in GI Malignancies Final - Handout.ppt - New Developments in GI... · CALGB 80101 – Overall Survival 0.6 0.8 1.0 n Surviving ECF 5-FU Overall Survival by Arm 01

CALGB 40903: Phase II Single-Arm Study of Neoadjuvant ......Clinical Research Professionals Education Meeting Friday May 9, 2014 CALGB 40903: Phase II Single-Arm Study of Neoadjuvant

Quarterly CALGB Newsletter, Summer 2010

060812 EEOC Response (CHINESE - Simplified)

News & Politics